Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NATCO PHARMA vs AJANTA PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NATCO PHARMA AJANTA PHARMA NATCO PHARMA/
AJANTA PHARMA
 
P/E (TTM) x 13.3 38.3 34.8% View Chart
P/BV x 3.5 8.3 42.0% View Chart
Dividend Yield % 0.6 0.3 184.8%  

Financials

 NATCO PHARMA   AJANTA PHARMA
EQUITY SHARE DATA
    NATCO PHARMA
Mar-23
AJANTA PHARMA
Mar-23
NATCO PHARMA/
AJANTA PHARMA
5-Yr Chart
Click to enlarge
High Rs8471,426 59.4%   
Low Rs5021,062 47.3%   
Sales per share (Unadj.) Rs148.4297.2 49.9%  
Earnings per share (Unadj.) Rs39.246.7 83.9%  
Cash flow per share (Unadj.) Rs48.257.1 84.4%  
Dividends per share (Unadj.) Rs5.507.00 78.6%  
Avg Dividend yield %0.80.6 144.9%  
Book value per share (Unadj.) Rs267.1269.1 99.3%  
Shares outstanding (eoy) m182.47125.91 144.9%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x4.54.2 108.6%   
Avg P/E ratio x17.226.6 64.6%  
P/CF ratio (eoy) x14.021.8 64.2%  
Price / Book Value ratio x2.54.6 54.6%  
Dividend payout %14.015.0 93.6%   
Avg Mkt Cap Rs m123,049156,638 78.6%   
No. of employees `000NANA-   
Total wages/salary Rs m4,8677,851 62.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m27,07137,426 72.3%  
Other income Rs m1,285986 130.3%   
Total revenues Rs m28,35638,413 73.8%   
Gross profit Rs m9,1177,833 116.4%  
Depreciation Rs m1,6381,308 125.2%   
Interest Rs m14558 248.3%   
Profit before tax Rs m8,6197,453 115.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,4661,573 93.2%   
Profit after tax Rs m7,1535,880 121.7%  
Gross profit margin %33.720.9 160.9%  
Effective tax rate %17.021.1 80.6%   
Net profit margin %26.415.7 168.2%  
BALANCE SHEET DATA
Current assets Rs m30,00328,252 106.2%   
Current liabilities Rs m6,83111,393 60.0%   
Net working cap to sales %85.645.0 190.0%  
Current ratio x4.42.5 177.1%  
Inventory Days Days6366 96.4%  
Debtors Days Days11510 1,119.9%  
Net fixed assets Rs m26,57118,707 142.0%   
Share capital Rs m365253 144.4%   
"Free" reserves Rs m48,37333,624 143.9%   
Net worth Rs m48,73833,877 143.9%   
Long term debt Rs m013 0.0%   
Total assets Rs m56,57447,047 120.3%  
Interest coverage x60.4128.6 47.0%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.50.8 60.2%   
Return on assets %12.912.6 102.2%  
Return on equity %14.717.4 84.6%  
Return on capital %18.022.2 81.1%  
Exports to sales %059.9 0.0%   
Imports to sales %10.211.5 89.3%   
Exports (fob) Rs mNA22,420 0.0%   
Imports (cif) Rs m2,7724,293 64.6%   
Fx inflow Rs m17,25622,420 77.0%   
Fx outflow Rs m2,7724,293 64.6%   
Net fx Rs m14,48418,127 79.9%   
CASH FLOW
From Operations Rs m8,4917,918 107.2%  
From Investments Rs m-4,771-5,596 85.3%  
From Financial Activity Rs m-3,630-1,079 336.5%  
Net Cashflow Rs m2081,243 16.7%  

Share Holding

Indian Promoters % 49.7 66.2 75.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 25.0 25.8 96.9%  
FIIs % 13.7 9.1 150.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 50.3 33.8 148.8%  
Shareholders   207,571 54,351 381.9%  
Pledged promoter(s) holding % 0.0 12.3 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NATCO PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Natco Pharma vs AJANTA PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Natco Pharma vs AJANTA PHARMA Share Price Performance

Period Natco Pharma AJANTA PHARMA S&P BSE HEALTHCARE
1-Day -2.11% 2.51% 1.18%
1-Month -3.19% 7.60% -0.75%
1-Year 72.80% 92.91% 61.82%
3-Year CAGR 4.96% 21.63% 18.16%
5-Year CAGR 10.96% 26.85% 19.79%

* Compound Annual Growth Rate

Here are more details on the Natco Pharma share price and the AJANTA PHARMA share price.

Moving on to shareholding structures...

The promoters of Natco Pharma hold a 49.7% stake in the company. In case of AJANTA PHARMA the stake stands at 66.2%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Natco Pharma and the shareholding pattern of AJANTA PHARMA.

Finally, a word on dividends...

In the most recent financial year, Natco Pharma paid a dividend of Rs 5.5 per share. This amounted to a Dividend Payout ratio of 14.0%.

AJANTA PHARMA paid Rs 7.0, and its dividend payout ratio stood at 15.0%.

You may visit here to review the dividend history of Natco Pharma, and the dividend history of AJANTA PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.